Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
Insulin has become, to your point, it's still a part of the business, a smaller share of the business. Again, this is of revenue, not of profits. But 22% of their revenue today comes from insulin. That leaves about 9% from the other efforts that they're putting energy into, rare diseases, things like hemophilia. They continue to be a ridiculously concentrated company.
0
💬
0
Comments
Log in to comment.
There are no comments yet.